Publication | Open Access
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
220
Citations
23
References
2023
Year
Phase 2B–3PharmacologyClinical DermatologyAlopecia AreataPharmacotherapySkin PharmacologyDermatologyMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1